This is good stuff.  Taking it a bit further than they did in August 2011 when they sketched “747” in the sky, Boeing Company (NYSE:BA) completed a 19-hour test flight of its 787 Dreamliner, doodling its way across the American skies.  Across thousands of miles between Iowa and Washington State, the numbers “787” and then a recognizable Boeing logo were the flight path.

Now, obviously, the flight path did not leave a trail that was discernible from the ground, but computer imagery of the flight path shows it plain as day.

Flight tracking company, FlightAware, coordinated with Boeing to provide the incredible images.  FlightAware Chief Executive Officer Daniel Baker said, “Boeing’s 19 hour test flight of the 787 Dreamliner was a great opportunity to test the limits of the 787, FlightAware’s flight tracking, and the FAA’s flight plan system.  It was the longest domestic flight we’ve ever handled and it required three FAA flight plans to accomplish, not to mention dozens of people coordinating the flight overnight.”

“This wasn’t a joy ride,” wrote Boeing’s vice president of marketing Randy Tinseth on the company’s blog. “It was an 18 hour Maximum ETOPS (Extended Operations) Duration flight test for a 787-8 with GE engines. Our team coordinated with the many air traffic control centers, choosing the routing to avoid restricted airspace. In the end, the flight covered over 9,000 nautical miles.”

Boeing (BA) Stock Quote and News:

---

Disclaimer: Neither http://www.otcshowcase.com nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. otcshowcase.com is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at http://www.otcshowcase.com/about-2/disclaimer.